CLINICAL_TRIALS
trial_result
· 2010-03-02
Clinical Trial Update: A Phase I Study of a Single Dose of Radio-labeled BMS-275183 in Patients With Advanced Cancer [Phase 1]
Summary
A Phase I study evaluating a single dose of radio-labeled BMS-275183 in patients with advanced cancer was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Cancer | Phase 1 | Status: TERMINATED